Platelets Outperform Leukocytes in Transcriptomic Liquid Biopsy Profiling of Myeloproliferative Neoplasms.
Platelet RNA signatures in blood could offer a simpler, more accurate way to diagnose and monitor blood cancers without tissue biopsies.
This bioRxiv preprint demonstrates that platelet RNA signatures are better than leukocyte RNA for distinguishing types of myeloproliferative neoplasms via liquid biopsy. This could improve non-invasive MPN diagnosis and monitoring.
What the study was
- Study design
- Comparative transcriptomic profiling
- Population
- Patients with myeloproliferative neoplasms
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- bioRxiv
Why it surfaced
Novel liquid biopsy approach for MPN using platelet transcriptomics. Preprint caps score; needs validation.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.